Performance of the Tuberculin Skin Test and Interferon-γ Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches

Giovanni Delogu, Delia Goletti, Alessandro Sanduzzi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

72 Citazioni (Scopus)

Abstract

An association between biologic agents and reactivation of active disease from latent tuberculosis infection (LTBI) has been established. Screening for LTBI is, therefore, now recommended for candidates for biologic drugs. The tuberculin skin test (TST) and interferon-γ release assays (IGRA) are the available commercial tests for detecting LTBI. We discuss their accuracy in immune-competent subjects and patients with autoimmune diseases, as well as potential new approaches to immune diagnosis. IGRA seem to be more accurate than TST in bacillus Calmette-Guerin vaccinated subjects and patients with autoimmune diseases. However, longitudinal studies are needed to estimate the risk of progression to TB after IGRA-based and/or TST-based diagnosis of LTBI in these vulnerable patients. New tests are needed to identify those patients with LTBI who will develop active TB and need prophylaxis.
Lingua originaleEnglish
pagine (da-a)24-31
Numero di pagine8
RivistaThe Journal of rheumatology. Supplement
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • ANTI-TUMOR NECROSIS FACTOR THERAPY
  • BIOLOGIC AGENTS
  • IGRA
  • LATENT TUBERCULOSIS
  • TST
  • TUBERCULOSIS

Fingerprint

Entra nei temi di ricerca di 'Performance of the Tuberculin Skin Test and Interferon-γ Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches'. Insieme formano una fingerprint unica.

Cita questo